FMII
UTHR icon

Farmers & Merchants Investments Inc’s United Therapeutics UTHR Stock Holding History

Farmers & Merchants Investments Inc’s Portfolio UTHR Stock Details UTHR Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$21.1K Hold
39
– – ﹤0.01% 598
2026
Q1 		$23.1K Sell
39
-1
-3% -$498 ﹤0.01% 560
2025
Q4 		$19.5K Hold
40
– – ﹤0.01% 565
2025
Q3 		$16.8K Buy
40
+3
+8% +$1.01K ﹤0.01% 599
2025
Q2 		$10.6K Buy
37
+4
+12% +$1.2K ﹤0.01% 706
2025
Q1 		$10.2K Buy
33
+15
+83% +$5.14K ﹤0.01% 689
2024
Q4 		$6.35K Sell
18
-1
-5% -$368 ﹤0.01% 761
2024
Q3 		$6.81K Hold
19
– – ﹤0.01% 751
2024
Q2 		$6.05K Hold
19
– – ﹤0.01% 756
2024
Q1 		$4.37K Hold
19
– – ﹤0.01% 789
2023
Q4 		$4.18K Hold
19
– – ﹤0.01% 792
2023
Q3 		$4.29K Sell
19
-2
-10% -$461 ﹤0.01% 763
2023
Q2 		$4.64K Hold
21
– – ﹤0.01% 768
2023
Q1 		$4.7K Hold
21
– – ﹤0.01% 737
2022
Q4 		$5.84K Hold
21
– – ﹤0.01% 743
2022
Q3 		$4K Buy
+21
New +$4.7K ﹤0.01% 806

Other funds holding UTHR

BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
AssetMark Inc
AssetMark Inc Concord, California $58.2B AUM 22.78% 1-Year Est. Return
Baillie Gifford & Co
Baillie Gifford & Co Edinburgh, United Kingdom $110B AUM 4.8% 1-Year Est. Return
Swedbank
Swedbank Stockholm, Sweden $116B AUM 46.87% 1-Year Est. Return
Bank of New York Mellon
Bank of New York Mellon New York $609B AUM 40.19% 1-Year Est. Return
LSV Asset Management
LSV Asset Management Chicago, Illinois $55.1B AUM 45.38% 1-Year Est. Return
Pictet Asset Management
Pictet Asset Management Carouge, Switzerland $105B AUM 38.07% 1-Year Est. Return
Citigroup
Citigroup New York $303B AUM 53.02% 1-Year Est. Return
Deutsche Bank
Deutsche Bank Frankfurt Am Main Ge, Germany $344B AUM 42.99% 1-Year Est. Return

Farmers & Merchants Investments Inc's UTHR Position: Q2 2026 in Review

Farmers & Merchants Investments Inc held its United Therapeutics (UTHR) position steady in Q2 2026 at 39 shares worth $21.1K. The position accounts for ﹤0.01% of the portfolio, ranked #598.

Farmers & Merchants Investments Inc first reported a position in UTHR in Q3 2022 and has held it in 16 quarters since. The position peaked at $23.1K in Q1 2026. 450 funds tracked by Wall St. Rank hold UTHR as of Q2 2026.

  • Farmers & Merchants Investments Inc held 39 shares of United Therapeutics worth $21.1K as of Q2 2026.
  • Farmers & Merchants Investments Inc left its United Therapeutics share count unchanged in Q2 2026.
  • United Therapeutics made up ﹤0.01% of Farmers & Merchants Investments Inc's portfolio in Q2 2026, its #598 holding.
  • Farmers & Merchants Investments Inc first reported a position in United Therapeutics in Q3 2022 and has held it in 16 quarters since.
  • Farmers & Merchants Investments Inc's United Therapeutics position peaked at $23.1K in Q1 2026.
  • 450 funds tracked by Wall St. Rank held United Therapeutics as of Q2 2026.

Based on Farmers & Merchants Investments Inc's 13F filing for Q2 2026, filed 20 Jul 2026.